Avenue Therapeutics, Inc.
ATXI· OTC
ATXIAvenue Therapeutics, Inc.
Filed Aug 11, 2017 · 10-Q · 42 days after period end · 0001144204-17-042457
| Metric | Q2 2017 | Q2 2016 |
|---|---|---|
| Net Income | -$2.41M | -$771.00K |
| EPS Diluted | -$0.70 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avenue Therapeutics, Inc. · CIK 1644963 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end
